Cytomegalovirus Infections News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Newly Published Data Highlight Moderna's mRNA Platform in Advancing Prophylactic Vaccine for Cytomegalovirus ... - Business Wire (press release)



Newly Published Data Highlight Moderna's mRNA Platform in Advancing Prophylactic Vaccine for Cytomegalovirus ... 
Business Wire (press release)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for high unmet medical needs in ...

and more » 


Why does CMV get so much less news coverage than Zika ? despite causing far more birth defects? - HealthNewsReview.org



HealthNewsReview.org
 
Why does CMV get so much less news coverage than Zika ? despite causing far more birth defects? 
HealthNewsReview.org
There are two viral diseases that, if they infect pregnant mothers, can cause birth defects and a range of other health problems for their babies. One disease affects thousands of infants each year in the United States, while the other affects fewer ...

 


Type of conditioning may increase infection risk for lymphoma subtype - Healio



Type of conditioning may increase infection risk for lymphoma subtype 
Healio
Researchers used serum polymerase chain reaction to evaluate infections that occurred from the start of conditioning to 6 months, using a combined viral infection endpoint that included cytomegalovirus, adenovirus, Epstein-Barr virus, BK virus, and ...

 


Vanderbilt Team to Study Virus Medication's Ability to Prevent Lung Tissue Scarring - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Vanderbilt Team to Study Virus Medication's Ability to Prevent Lung Tissue Scarring 
Pulmonary Fibrosis News
Researchers at Vanderbilt University Medical Center plan a Phase 1 clinical trial to evaluate the virus medication Valcyte's ability to prevent lung tissue scarring in idiopathic pulmonary fibrosis patients. The trial (NCT02871401) will cover 30 IPF ...

 


Letermovir Prophylaxis Lowers CMV Risk in HCT Patients - Clinical Oncology News



Clinical Oncology News
 
Letermovir Prophylaxis Lowers CMV Risk in HCT Patients 
Clinical Oncology News
The recently approved antiviral drug letermovir lowered the risk for clinically significant cytomegalovirus (CMV) infection compared with placebo in CMV-seropositive recipients of allogeneic hematopoietic cell transplant (allo-HCT) in a recent study ...

 


A Deeper Look at Atara Biotherapeutics' ATA129, ATA520, and ATA230 - Market Realist



Market Realist
 
A Deeper Look at Atara Biotherapeutics' ATA129, ATA520, and ATA230 
Market Realist
Atara Biotherapeutics' fourth T-cell product candidate ATA230 is a third-party-derived cytomegalovirus (or CMV). Allogeneic cytotoxic T-lymphocyte (or CTL) is in a phase-2 clinical trial for refractory CMV infection that occurs in some patients whose ...
Products & Sign Up - Stock valuation and analysis, newsletter, analysis report, institutional software Stock valuation and analysis, newsletter, analysis report, institutional software
Atara Biotherapeutics, Inc. - ATRA - Stock Price Today - Zacks Zacks

all 80 news articles » 


Expert Discusses Letermovir Approval for CMV Prophylaxis Post-Transplantation - OncLive



OncLive
 
Expert Discusses Letermovir Approval for CMV Prophylaxis Post-Transplantation 
OncLive
Perales: One of the exciting developments is the approval of letermovir, which is a drug that we use to prevent infection with CMV in patients undergoing stem cell transplant. This is an important regimen in many ways. The current management involves ...

 


Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct ... - Journal of Virology



Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct ... 
Journal of Virology
Human cytomegalovirus (HCMV) is a prevalent pathogen that establishes lifelong infection in the host. Virus persistence is aided by extensive manipulation of the host immune system, particularly cytokine and chemokine signaling pathways. The HCMV ...

 


Cytomegalovirus (CMV) Infection Market Overview, Development, Diagnosis and Treatment for 2027 - The Financial



Cytomegalovirus (CMV) Infection Market Overview, Development, Diagnosis and Treatment for 2027 
The Financial
Cytomegalovirus (CMV) Infection ? Market Insights, Epidemiology and Market Forecast ? 2027?? report provides a detailed analysis of the Cytomegalovirus (CMV) Infection epidemiology and market outlook for the 7MM.United States, EU5 (Germany, France ...

 


Omeros (OMER) Reports Significant Improvement in OS Data in OMS721-Treated Patients with HCT-TMA - StreetInsider.com



Omeros (OMER) Reports Significant Improvement in OS Data in OMS721-Treated Patients with HCT-TMA 
StreetInsider.com
Other serious co-existing conditions included graft versus host disease (GvHD), cytomegalovirus and human herpes virus 6 infections, prior sepsis, diffuse alveolar hemorrhage, and residual underlying malignancies. OMS721 has been well tolerated and no ...

and more »